Summary of findings 3. Mobile stroke team versus general medical ward.
| Mobile stroke team care compared with general medical ward care for stroke | ||||||
|
Patient or population: adults with acute stroke Settings: hospital Intervention: mobile stroke team care Comparison: general medical ward care | ||||||
| Outcomes | Illustrative comparative risks* (95% CI) | Relative effect (95% CI) | Number of participants (studies) | Quality of the evidence (GRADE) | Comments | |
| Assumed risk | Corresponding risk | |||||
| General medical ward care | Mobile stroke team care | |||||
|
Poor outcome by the end of scheduled follow‐up (modified Rankin score 3 to 6 or requiring institutional care; median 12‐month follow‐up) (Analysis 3.1) |
712 per 1000 | 672 per 1000 (582 to 752) |
OR 0.80 (0.52 to 1.22) |
438 (2) |
⊕⊕⊝⊝ lowa,b | As dependency data were complete, these are the same data as for death or dependency |
|
Death by the end of scheduled follow‐up (median 12‐month follow‐up) (Analysis 3.2) |
259 per 1000 | 279 per 1000 (189 to 359) |
OR 1.08 (0.71 to 1.65) |
438 (2) |
⊕⊕⊝⊝ lowa,b | |
|
Death or institutional care by the end of scheduled follow‐up (median 12‐month follow‐up) (Analysis 3.3) |
481 per 1000 | 531 per 1000 (451 to 611) |
OR 1.27 (0.84 to 1.93) |
438 (2) |
⊕⊕⊝⊝ lowa,b | |
|
Death or dependency by the end of scheduled follow‐up (modified Rankin score 3 to 6; median 12‐month follow‐up) (Analysis 3.4) |
712 per 1000 | 672 per 1000 (582 to 752) |
OR 0.80 (0.52 to 1.22) |
438 (2) |
⊕⊕⊝⊝ lowa,b | As dependency data were complete, these are the same data as for poor outcome |
|
Subjective health status score Participant quality of life (EuroQol) |
No apparent differences between groups | N/A | 308 (1) |
⊕⊝⊝⊝ very lowa,b |
Data from 1 trial only | |
| Patient satisfaction or preference | We could find no systematically gathered information on patient preferences | N/A | N/A | N/A | No data available | |
|
Length of stay (days) in a hospital or institution (Analysis 3.5) |
No data available | N/A | N/A | N/A | No data available | |
| *The basis for the assumed risk (e.g. median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: confidence interval; N/A: not applicable; OR: odds ratio. | ||||||
| GRADE Working Group grades of evidence. High quality: further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: we are very uncertain about the estimate. | ||||||
aDowngraded for potential risk of performance bias.
bDowngraded for imprecision.